NDV HUJ

Drug Profile

NDV HUJ

Alternative Names: OV-001; TV-7000

Latest Information Update: 11 Aug 2011

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Hebrew University of Jerusalem
  • Class Antineoplastics; Oncolytic viruses
  • Mechanism of Action
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported Glioblastoma

Most Recent Events

  • 11 Jul 2006 Final results from a phase I/II clinical trial in patients with glioblastoma multiforme have been added to the adverse events and Cancer therapeutic trials sections
  • 26 Jul 2005 OVCure is now called Theravir Management
  • 07 Jul 2004 Phase-I/II clinical trials in Glioblastoma in Israel (IV-infusion)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top